News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes Presenter: Michael J. Mack, John D. Carroll June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network Presenter: Michael J. Mack June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN) Presenter: Michael J. Mack, John C Laschinger June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Megan Coylewright June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives on the Hierarchy of Valve Centers of Excellence in the US Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Brian R Lindman June 21, 2018